Provided by Tiger Trade Technology Pte. Ltd.

Artelo Biosciences, Inc.

0.6920
-0.0204-2.86%
Post-market: 0.6815-0.0105-1.52%19:09 EDT
Volume:108.90K
Turnover:76.98K
Market Cap:3.18M
PE:-0.06
High:0.7300
Open:0.7200
Low:0.6803
Close:0.7124
52wk High:28.98
52wk Low:0.6803
Shares:4.60M
Float Shares:4.35M
Volume Ratio:0.07
T/O Rate:2.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-11.3794
EPS(LYR):-37.5481
ROE:-705.71%
ROA:-127.92%
PB:0.64
PE(LYR):-0.02

Loading ...

Major US Stock Indices Climb Over 1%

Deep News
·
Apr 17

Artelo Biosciences Files Offering for 9.8 Million Common Stock; Shares Tumble

MT Newswires Live
·
Apr 08

Artelo Biosciences files to sell 9.82M shares of common stock for holders

TIPRANKS
·
Apr 08

Artelo Biosciences regains Nasdaq listing compliance after equity, annual meeting violations

Reuters
·
Apr 07

Artelo Biosciences Regains Compliance With Nasdaq Listing Requirements

THOMSON REUTERS
·
Apr 07

Top Premarket Gainers

MT Newswires Live
·
Mar 31

Artelo Biosciences closes USD 11 million private placement priced at-market under Nasdaq rules

Reuters
·
Mar 31

Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
Mar 31

Top Premarket Decliners

MT Newswires Live
·
Mar 30

Artelo Biosciences Soars 230% on Obesity Push — Why Is ARTL Stock Now Crashing?

TIPRANKS
·
Mar 30

Top Midday Gainers

MT Newswires Live
·
Mar 28

BUZZ-U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services

Reuters
·
Mar 27

Artelo Biosciences announces $11.0 million private placement; shares price at $3.45 under Nasdaq rules

Reuters
·
Mar 27

Artelo Biosciences Announces $11.0 Million Private Placement Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
Mar 27

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM

Reuters
·
Mar 27

Artelo announces expansion opportunity for ART27.13 in muscle preservation

TIPRANKS
·
Mar 26

Artelo Biosciences initiates non-clinical study of ART27.13 for GLP-1-related muscle loss; incretin market climbs to $200 billion by 2030 forecast

Reuters
·
Mar 26

Artelo Biosciences Expands Art27.13 Development as a Potential Companion Therapy to Glp-1 Treatments

THOMSON REUTERS
·
Mar 26

Artelo Biosciences expands ART27.13 into glaucoma via fully funded investigator-sponsored clinical study; glaucoma market totals $16.3 billion

Reuters
·
Mar 25

Artelo Biosciences files to sell 4.27M shares of common stock for holders

TIPRANKS
·
Mar 25